Chu Crystal, Dengel Lynn T, Petroni Gina R, Hollen Patricia J, Jones Randy A
Crystal Chu.
Lynn T. Dengel.
Oncol Nurs Forum. 2025 Feb 18;52(2):E58-E64. doi: 10.1188/25.ONF.E58-E64.
The use of a decision aid (DA) for women facing the decision of contralateral prophylactic mastectomy (CPM) is limited. This article aimed to examine the literature for studies testing a DA for patients diagnosed with unilateral breast cancer considering CPM.
A comprehensive search was conducted in CINAHL®, Ovid MEDLINE®, PubMed®, Web of Science, PsycINFO®, and Cochrane Library databases from 2017 to 2024.
The studies were assessed for relevance in testing a patient DA for CPM in patients diagnosed with unilateral breast cancer. Studies were evaluated using the Mixed Methods Appraisal Tool, version 2018.
Five studies met inclusion criteria. These studies included one pre-/postassessment cohort pilot study, one randomized controlled trial, two mixed-methods studies, and one qualitative study. Studies included 370 patients and 50 clinicians in the breast oncology setting.
Oncology nurses can play a key role in advocating for shared decision-making for patients considering CPM. Additional testing of a DA for patients diagnosed with unilateral breast cancer considering CPM should be considered.
对于面临对侧预防性乳房切除术(CPM)决策的女性,决策辅助工具(DA)的使用有限。本文旨在检索文献,查找针对被诊断为单侧乳腺癌且考虑进行CPM的患者测试DA的研究。
2017年至2024年期间,在CINAHL®、Ovid MEDLINE®、PubMed®、Web of Science、PsycINFO®和Cochrane图书馆数据库中进行了全面检索。
评估这些研究对于在被诊断为单侧乳腺癌的患者中测试CPM患者DA的相关性。使用2018版混合方法评估工具对研究进行评估。
五项研究符合纳入标准。这些研究包括一项前后评估队列试点研究、一项随机对照试验、两项混合方法研究和一项定性研究。研究纳入了乳腺肿瘤领域的370名患者和50名临床医生。
肿瘤护士在倡导为考虑CPM的患者进行共同决策方面可发挥关键作用。应考虑对被诊断为单侧乳腺癌且考虑进行CPM的患者进一步测试DA。